• ANI Pharmaceuticals SVP and CFO Stephen P. Carey sold 2,850 shares of Common Stock on Oct. 29, 2026.
• The reported sale price was $72.87 per share.
• Carey directly owned 166,143 shares following the transaction, according to the Form 4 dated Oct. 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001674236-26-000026), on October 30, 2026, and is solely responsible for the information contained therein.